显性负调突变体抗乙肝病毒感染基因治疗研究进展

Research progress of gene therapy for infection by dominant negative mutation of HBV

下载PDF

导出

作者武文斌

机构地区第二军医大学研究生院

出处《海军医学杂志》 2005年第1期68-70,共3页 Journal of Navy Medicine

关键词突变体乙肝病毒基因治疗

参考文献15

1BIENBAUM F, NASSAL M. Hepatitis B virus capsid assembly:primary structure requirement[J]. J Virol, 1990, 64:3 319 -3 330.
2LAU J Y N, WRIGHT T L. Molecular virology and pathogenesis of hepatitis B[J]. Lancet, 1993, 342:1 335 - 1 339.
3RICHARD W. Gene inhibition using antisense oligodeoxynucleotides[J]. Nature, 1995, 372:333- 335
4VON WEIZSACKER F, HUBERT E B, WANDS J R. Ceavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA tepmlate [J ]. Biophysical Research Communication,1992, 189: 743 - 747.
5HERSKOWITZ. Functional inactivation of genes by dominant negative mutations[J]. Nature, 1987, 329: 219 - 222.
6FRIEDMAN A D. Expression of a truncated trans - activator seleetively impedes lytic infection its cognate virus [ J ]. Nature,1988, 335:452 - 454.
7BALTIMORE D. Intracellular immunization. Nature, 1988,335:395 - 396.
8TRONO D, TEINBERG M B, BALTIMORE D. HIV- lgag mutants can dominantly interfere with the replication of the "wild type" virus[J]. Cell, 1989, 59:113 - 120.
9HORWICH, FURTAK K, PUGH J, et al. Synthes is of hepadnavirus particles that contain replication defective duck hepatitis B virus genomes in cultured HuH7 cells[J]. J Virol, 1990, 64:642-650.
10SCAGLIONI P P, MELREGARY M, WANDS J. Characterization of hepatitis B virus core mutants that inhibit viral replication[J]. Virology, 1994, 205:112 - 120.

海军医学杂志

2005年第1期

内容加载中请稍等...